Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of cataracts, technological advances in phacoemulsification, and initiatives to increase awareness and access to phacoemulsification in developing countries.
The phacoemulsification devices market is segmented as below:
By Product
- Phacoemulsification consumables
- Phacoemulsification systems
By End-user
- Hospitals
- Clinics
- Research institutes
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the phacoemulsification devices market covers the following areas:
- Phacoemulsification devices market sizing
- Phacoemulsification devices market forecast
- Phacoemulsification devices market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
Executive Summary
The publisher recognizes the following companies as the key players in the global phacoemulsification devices market: Alcon Inc., Bausch Health Companies Inc., Carl Zeiss AG, Escalon Medical Corp., Glaukos Corp., Halma Plc, HOYA Corp., HumanOptics Holding AG, Johnson and Johnson, Lenstec Inc., LIGHTMED Corp., LUMed GmbH, Medical Technical Products, Metall Zug AG, NIDEK Co. Ltd., Rayner, SIFI SPA, STAAR Surgical Co., Topcon Corp., and Ziemer Ophthalmic Systems AG.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is glaucoma surgery combined with cataract surgery via phacoemulsification.'
According to the report, one of the major drivers for this market is the increasing prevalence of cataracts.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alcon Inc.
- Bausch Health Companies Inc.
- Carl Zeiss AG
- Escalon Medical Corp.
- Glaukos Corp.
- Halma Plc
- HOYA Corp.
- HumanOptics Holding AG
- Johnson and Johnson
- Lenstec Inc.
- LIGHTMED Corp.
- LUMed GmbH
- Medical Technical Products
- Metall Zug AG
- NIDEK Co. Ltd.
- Rayner
- SIFI SPA
- STAAR Surgical Co.
- Topcon Corp.
- Ziemer Ophthalmic Systems AG